The Role of Niacin in the Management of Dyslipidemia†

Journal of Clinical Lipidology - Netherlands
doi 10.1016/j.jacl.2019.04.052
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

6. Update for the Management of Dyslipidemia

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
2019English

Management of Dyslipidemia in Elderly Patients

Japanese Journal of Geriatrics
GerontologyGeriatrics
2014English

The Role of Microbiota in Pathogenesis of Dyslipidemia and Associated Metabolic Disorders

Dokazatel'naya gastroenterologiya
2017English

A Clinical Study to Evaluate the Efficacy of Vamana Karma in the Management of Dyslipidemia

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2018English

Atherosclerosis in Children and the Role of Dyslipidemia in Its Development (Lecture. Part 1)

Health of Society
2017English

Atherosclerosis in Children and the Role of Dyslipidemia in Its Development (Lecture. Part 2)

Health of Society
2018English

Management of Dyslipidemia in Children and Adolescents With Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2003English

The ODYSSEY DM-DYSLIPIDEMIA Trial: Confirming the Benefits of Alirocumab in Diabetic Mixed Dyslipidemia

Annals of Translational Medicine
Medicine
2017English

Role of Dyslipidemia and Lipid Peroxidation in Pregnancy Induced Hypertension

Journal of Clinical and Scientific Research
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy